|
|
Article: Dresdner Kleinwort Wasserstein Launches Biotechnology Industry Coverage; Also Makes Key Industry Investment Banking Hires.
- Article from:
- Business Wire
- Article date:
- September 26, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
NEW YORK--(BUSINESS WIRE)--Sept. 26, 2001
Dresdner Kleinwort Wasserstein (DrKW) today announced initiation of equity research coverage of the biotechnology industry sector by leading analyst Charles C. Duncan, Ph.D.
The firm also announced key additions to its Healthcare Investment Banking team.
Paul Adams, Head of Healthcare Investment Banking commented, "DrKW is firmly committed to a leadership position in the global biopharmaceutical industry. Our integrated global approach leverages our traditional strength in Europe with the rapid expansion of our U.S. capabilities in investment banking, sales and trading and ...